UNH stock sentiment todayUnitedHealth Group Inc
Sentiment verdict
Gossip first, financials second — NEUTRAL at 75% confidence.
Last updated · cached analysis, refreshes periodically
UNH
UnitedHealth Group IncA healthcare titan facing short-term regulatory and cyber-recovery headwinds, despite robust long-term fundamental strength.
Pick a name and you can add your own 1-, 3- and 6-month price calls — no account needed. The needle above shows where the crowd sits. Calls lock 48 hours after you make them, so every scorecard stays honest.
You'll show up on boards and The Floor under this name. Add an email later to keep your history.
No account needed. You can add an email later to keep your calls.
Already have an account? Sign in
See exactly how analyst targets, gossip sentiment and momentum are weighted into this 6-month forecast.
Sign in to go Pro →Full model breakdown (analyst / gossip / momentum weights) is a Pro feature. Modelled for UNH. Not financial advice.
Price · last 12 months
Gossip
The narrative is currently dominated by the fallout from the Change Healthcare cyberattack and intensifying scrutiny over Medicare Advantage rates. Investors are concerned about rising medical loss ratios (MLR) and the potential for increased government regulation regarding PBM (Pharmacy Benefit Manager) transparency.
- ·Change Healthcare cyberattack recovery costs
- ·Lower-than-expected 2025 Medicare Advantage reimbursement rates
- ·DOJ antitrust investigation into the Optum-UnitedHealth relationship
- ·Increased utilization of outpatient services by seniors
Financial
UnitedHealth maintains a dominant market position with a diversified revenue stream between its insurance arm and Optum services. While recent margins are pressured by the cyberattack, its return on equity (ROE) and historical earnings growth remain top-tier in the managed care space.
- ·Double-digit long-term EPS growth target (13-16%)
- ·Strong cash flow generation despite one-time disruptions
- ·Consistent dividend CAGR exceeding 15% over the last 5 years
- ·Robust Optum health services growth offsetting insurance volatility
Conviction
Whose money is actually in the stock — insider open-market trades and the patience of the institutional holder base.
Mixed conviction — no decisive signal from insiders or the holder base.
- ·Insiders sold a net $661K on the open market in the last 120 days.
Pro shows every named insider trade in the window (buyer, title, size, price, and whether it was a pre-scheduled 10b5-1 sale) plus the full holder register split into patient capital and fast money.
Unlock with Pro →Source: SEC EDGAR Form 4 + 13F holder register. Option exercises, grants, gifts and tax withholding are excluded — only open-market purchases and sales count. Not financial advice.
Risks
- ·Heightened regulatory pressure on PBM margins
- ·Medical Loss Ratio (MLR) expansion due to increased care utilization
- ·Integration risks with ongoing M&A strategy
- ·Political headline risk ahead of the U.S. election cycle
Peer temperature
How direct competitors stack up against UNH right now.
- HOTELVElevance Health
HOTTER — trading at a more attractive forward P/E with less exposure to the specific DOJ antitrust scrutiny facing UNH's integrated model.
See full analysis → - COLDCVSCVS Health
COLDER — struggling with significant Aetna-related margin compression and a more complex debt profile following heavy acquisitions.
See full analysis → - COLDHUMHumana Inc.
COLDER — higher concentration in Medicare Advantage makes them significantly more vulnerable to the current unfavorable reimbursement environment than UNH.
See full analysis →
- UNH-3.8%
- ELV+4.2%
- CVS-2.4%
- HUM+10.4%
Analyst price target
Consensus average of 21 analysts · median 478.00
Source: StockAnalysis.com · updated 2026-09-04
AI-generated analysis for informational purposes only. Not financial advice.